ASTRAZENECA UK LIMITED
Patent Owner
Stats
- 176 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 23, 2017 most recent publication
Details
- 176 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 9,397 Total Citation Count
- Jul 15, 1983 Earliest Filing
- 323 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9371291 Process for the manufacture of the calcium salt of rosuvastatin (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S)-3,5-Dihydroxyhept-6-enoic acid and crystalline intermediates thereofJul 19, 11Jun 21, 16[C07D]
8475842 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneOct 07, 09Jul 02, 13[A61K, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0173,010 IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONEAbandonedMar 03, 17Jun 22, 17[A61K]
2016/0008,473 IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONEAbandonedApr 16, 15Jan 14, 16[A61K]
2015/0152,111 TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITIONAbandonedJun 20, 14Jun 04, 15[C07D]
2014/0296,258 TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITONAbandonedOct 31, 13Oct 02, 14[C07D]
2014/0079,778 Pharmaceutical Formulations Including An Amine CompoundAbandonedJan 31, 12Mar 20, 14[A61K]
2014/0066,447 IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONEAbandonedJun 06, 13Mar 06, 14[A61K]
2013/0225,622 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium SaltAbandonedApr 08, 13Aug 29, 13[C07D]
2013/0112,194 PROCESS FOR PROVIDING A FILLED CANISTER FOR AN INHALERAbandonedFeb 09, 11May 09, 13[B65B, A61M]
2013/0109,702 TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITIONAbandonedOct 31, 12May 02, 13[C07D]
2013/0072,503 TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITIONAbandonedMar 19, 12Mar 21, 13[C07D]
2012/0318,343 SILICON-FREE ALUMINUM PASTE COMPOSITION FOR FORMING AN ALUMINUM BACK ELECTRODE WITH LARGE SILICON PARTICLESAbandonedDec 16, 11Dec 20, 12[H01L, H01B]
2011/0251,406 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED-1,-3-DIOXANE-4-YL) ACETIC ACID DERIVATIVESAbandonedJun 22, 11Oct 13, 11[C07D]
2011/0071,144 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMAbandonedApr 23, 10Mar 24, 11[A61K, C07D, A61P]
2010/0256,153 METHODS FOR PREVENTING OR REDUCING RISK OF MORTALITYAbandonedMar 26, 10Oct 07, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.